Evaluation of the prognosis for small hepatocellular carcinoma based on tumor volume doubling time. A preliminary reportNobuo Okazaki, Setsuo Hirohashi, Masahiro Yoshino et al.|Cancer|1989Cited by 119
Randomized, phase II trial of sequential hepatic arterial infusion chemotherapy and sorafenib versus sorafenib alone as initial therapy for advanced hepatocellular carcinoma: SCOOP-2 trialMasaaki Kondo, Katsuaki Tanaka, Masataka Taguri et al.|BMC Cancer|2019Cited by 77
Hepatic artery embolization for inoperable hepatocellular carcinoma; prognosis and Risk FactorsKenichi Takayasu, Hiroshi Hasegawa, Michihiro Suzuki et al.|Cancer Chemotherapy and Pharmacology|1989Cited by 55
Field practice study of half‐dose sorafenib treatment on safety and efficacy for hepatocellular carcinoma: A propensity score analysisManabu Morimoto, Katsuaki Tanaka, Kazushi Numata et al.|Hepatology Research|2014Cited by 30
Hepatic arterial infusion chemotherapy with cisplatin and sorafenib in hepatocellular carcinoma patients unresponsive to transarterial chemoembolization: A propensity score‐based weightingMasaaki Kondo, Katsuaki Tanaka, Manabu Morimoto et al.|Journal of Digestive Diseases|2014Cited by 20